Woodline Partners LP Agenus Inc Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$1.12 - $1.88 $725,717 - $1.22 Million
647,962 New
647,962 $732,000
Q1 2022

May 16, 2022
SELL
$2.35 - $3.47 $1.55 Million - $2.28 Million
-657,495 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.92 - $5.74 $1.92 Million - $3.77 Million
657,495 New
657,495 $2.12 Million

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email